BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24260486)

  • 1. The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1.
    Fendler A; Jung M; Stephan C; Erbersdobler A; Jung K; Yousef GM
    PLoS One; 2013; 8(11):e80807. PubMed ID: 24260486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1.
    Haflidadóttir BS; Larne O; Martin M; Persson M; Edsjö A; Bjartell A; Ceder Y
    PLoS One; 2013; 8(8):e72400. PubMed ID: 23951320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1.
    Wu Z; Sun H; Zeng W; He J; Mao X
    PLoS One; 2012; 7(9):e45825. PubMed ID: 23029264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.
    Yu JJ; Wu YX; Zhao FJ; Xia SJ
    Med Oncol; 2014 Apr; 31(4):910. PubMed ID: 24633705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
    Gao F; Wang W
    Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-3174 promotes proliferation and inhibits apoptosis by targeting FOXO1 in hepatocellular carcinoma.
    Wang Q; Yang X; Zhou X; Wu B; Zhu D; Jia W; Chu J; Wang J; Wu J; Kong L
    Biochem Biophys Res Commun; 2020 Jun; 526(4):889-897. PubMed ID: 32279994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
    Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
    PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-582-5p is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO1.
    Liu Y; Jiang J; Wang X; Zhai F; Cheng X
    PLoS One; 2013; 8(10):e78381. PubMed ID: 24205217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2.
    Sun XB; Chen YW; Yao QS; Chen XH; He M; Chen CB; Yang Y; Gong XX; Huang L
    Technol Cancer Res Treat; 2021; 20():1533033821989817. PubMed ID: 33550923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells.
    Guttilla IK; White BA
    J Biol Chem; 2009 Aug; 284(35):23204-16. PubMed ID: 19574223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer.
    Li X; Wan X; Chen H; Yang S; Liu Y; Mo W; Meng D; Du W; Huang Y; Wu H; Wang J; Li T; Li Y
    Clin Cancer Res; 2014 May; 20(9):2312-25. PubMed ID: 24610824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1.
    Kim KM; Park SJ; Jung SH; Kim EJ; Jogeswar G; Ajita J; Rhee Y; Kim CH; Lim SK
    J Bone Miner Res; 2012 Aug; 27(8):1669-79. PubMed ID: 22431396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
    Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
    Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-96 expression in prostate cancer and its effect on the target gene regulation.
    Bao YH; Wang Y; Liu Y; Wang S; Wu B
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4548-4556. PubMed ID: 29131261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma.
    Song W; Li Q; Wang L; Wang L
    Cell Physiol Biochem; 2015; 35(1):184-90. PubMed ID: 25591761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
    Myatt SS; Wang J; Monteiro LJ; Christian M; Ho KK; Fusi L; Dina RE; Brosens JJ; Ghaem-Maghami S; Lam EW
    Cancer Res; 2010 Jan; 70(1):367-77. PubMed ID: 20028871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-221-3p regulates apoptosis of ovarian granulosa cells via targeting FOXO1 in older women with diminished ovarian reserve (DOR).
    Wei C; Xiang S; Yu Y; Song J; Zheng M; Lian F
    Mol Reprod Dev; 2021 Apr; 88(4):251-260. PubMed ID: 33694202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
    Mao XP; Zhang LS; Huang B; Zhou SY; Liao J; Chen LW; Qiu SP; Chen JX
    J Transl Med; 2015 Mar; 13():86. PubMed ID: 25888950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.